{"id":"https://openalex.org/W4407636645","doi":"https://doi.org/10.1016/j.ctrv.2025.102901","title":"Comparative efficacy and safety of pyrotinib plus trastuzumab versus trastuzumab plus pertuzumab and trastuzumab monotherapy in neoadjuvant treatment of HER2-positive breast cancer: A systematic review and meta-analysis","display_name":"Comparative efficacy and safety of pyrotinib plus trastuzumab versus trastuzumab plus pertuzumab and trastuzumab monotherapy in neoadjuvant treatment of HER2-positive breast cancer: A systematic review and meta-analysis","publication_year":2025,"publication_date":"2025-02-18","ids":{"openalex":"https://openalex.org/W4407636645","doi":"https://doi.org/10.1016/j.ctrv.2025.102901","pmid":"https://pubmed.ncbi.nlm.nih.gov/39986012"},"language":"en","primary_location":{"id":"doi:10.1016/j.ctrv.2025.102901","doi":"https://doi.org/10.1016/j.ctrv.2025.102901","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ctrv.2025.102901","pdf_url":"https://www.cancertreatmentreviews.com/article/S0305-7372(25)00023-4/pdf","source":{"id":"https://openalex.org/S49831067","display_name":"Cancer Treatment Reviews","issn_l":"0305-7372","issn":["0305-7372","1532-1967"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Treatment Reviews","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://www.cancertreatmentreviews.com/article/S0305-7372(25)00023-4/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5031309057","display_name":"Ye Yuan","orcid":"https://orcid.org/0000-0001-8594-7970","observed_orcids":["https://orcid.org/0000-0001-8594-7970"]},"institutions":[{"id":"https://openalex.org/I4210133148","display_name":"Sichuan Integrative Medicine Hosipital","ror":"https://ror.org/032z6r127","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210133148"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Ye Yuan","raw_affiliation_strings":["Sichuan Integrative Medicine Hospital, China. Electronic address: yuanyeah0811@163.com"],"raw_orcid":"https://orcid.org/0000-0001-8594-7970","affiliations":[{"raw_affiliation_string":"Sichuan Integrative Medicine Hospital, China. Electronic address: yuanyeah0811@163.com","institution_ids":["https://openalex.org/I4210133148"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027665566","display_name":"Xumei Liu","orcid":"https://orcid.org/0000-0001-9218-2822","observed_orcids":["https://orcid.org/0000-0001-9218-2822"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xumei Liu","raw_affiliation_strings":["Chengdu Anticancer Bioscience, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chengdu Anticancer Bioscience, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107842819","display_name":"Gang Xu","orcid":"https://orcid.org/0009-0008-8853-6067","observed_orcids":["https://orcid.org/0009-0008-8853-6067"]},"institutions":[{"id":"https://openalex.org/I4210133148","display_name":"Sichuan Integrative Medicine Hosipital","ror":"https://ror.org/032z6r127","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210133148"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Gaifeng Xu","raw_affiliation_strings":["Sichuan Integrative Medicine Hospital, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sichuan Integrative Medicine Hospital, China","institution_ids":["https://openalex.org/I4210133148"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100329269","display_name":"Ji Zhang","orcid":"https://orcid.org/0000-0002-6538-6392","observed_orcids":["https://orcid.org/0000-0002-6538-6392"]},"institutions":[{"id":"https://openalex.org/I4210133148","display_name":"Sichuan Integrative Medicine Hosipital","ror":"https://ror.org/032z6r127","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210133148"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Ji Zhang","raw_affiliation_strings":["Sichuan Integrative Medicine Hospital, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sichuan Integrative Medicine Hospital, China","institution_ids":["https://openalex.org/I4210133148"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100379172","display_name":"Li Chen","orcid":"https://orcid.org/0000-0001-7670-8062","observed_orcids":["https://orcid.org/0000-0001-7670-8062","https://orcid.org/0000-0001-9621-9231"]},"institutions":[{"id":"https://openalex.org/I4210133148","display_name":"Sichuan Integrative Medicine Hosipital","ror":"https://ror.org/032z6r127","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210133148"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Li Chen","raw_affiliation_strings":["Sichuan Integrative Medicine Hospital, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sichuan Integrative Medicine Hospital, China","institution_ids":["https://openalex.org/I4210133148"]}]},{"author_position":"last","author":{"id":null,"display_name":"Xin Long","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210133148","display_name":"Sichuan Integrative Medicine Hosipital","ror":"https://ror.org/032z6r127","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210133148"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Xin Long","raw_affiliation_strings":["Sichuan Integrative Medicine Hospital, China. Electronic address: 26011707@qq.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sichuan Integrative Medicine Hospital, China. Electronic address: 26011707@qq.com","institution_ids":["https://openalex.org/I4210133148"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5031309057"],"corresponding_institution_ids":["https://openalex.org/I4210133148"],"apc_list":{"value":4910,"currency":"USD","value_usd":4910},"apc_paid":{"value":4910,"currency":"USD","value_usd":4910},"fwci":0.6015,"has_fulltext":true,"cited_by_count":6,"citation_normalized_percentile":{"value":0.53957358,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":95,"max":97},"biblio":{"volume":"134","issue":null,"first_page":"102901","last_page":"102901"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.003000000026077032,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10696","display_name":"Gastric Cancer Management and Outcomes","score":0.00139999995008111,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pyrotinib","display_name":"pyrotinib","score":0.9350000023841858},{"id":"https://openalex.org/keywords/trastuzumab","display_name":"trastuzumab","score":0.9990000128746033},{"id":"https://openalex.org/keywords/pertuzumab","display_name":"pertuzumab","score":0.9909999966621399},{"id":"https://openalex.org/keywords/her2-positive-breast-cancer","display_name":"HER2-positive breast cancer","score":0.996999979019165},{"id":"https://openalex.org/keywords/neoadjuvant-therapy","display_name":"neoadjuvant therapy","score":0.984000027179718},{"id":"https://openalex.org/keywords/pathological-complete-response","display_name":"pathological complete response","score":0.7419999837875366},{"id":"https://openalex.org/keywords/treatment-efficacy","display_name":"treatment efficacy","score":0.34299999475479126},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.8209999799728394},{"id":"https://openalex.org/keywords/her2-targeted-therapy","display_name":"HER2-targeted therapy","score":0.6240000128746033},{"id":"https://openalex.org/keywords/locally-advanced-breast-cancer","display_name":"locally advanced breast cancer","score":0.8899999856948853},{"id":"https://openalex.org/keywords/early-breast-cancer","display_name":"early breast cancer","score":0.9229999780654907},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.40299999713897705},{"id":"https://openalex.org/keywords/quality-of-life","display_name":"quality of life","score":0.4860000014305115},{"id":"https://openalex.org/keywords/patient-reported-outcomes","display_name":"patient-reported outcomes","score":0.3659999966621399}],"concepts":[{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.981885552406311},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9650428891181946},{"id":"https://openalex.org/C2781164504","wikidata":"https://www.wikidata.org/wiki/Q1998021","display_name":"Pertuzumab","level":5,"score":0.9511535167694092},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6970531344413757},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.5968123078346252},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5797573328018188},{"id":"https://openalex.org/C95190672","wikidata":"https://www.wikidata.org/wiki/Q815382","display_name":"Meta-analysis","level":2,"score":0.5057835578918457},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3169906735420227}],"mesh":[{"descriptor_ui":"D000068878","descriptor_name":"Trastuzumab","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000068878","descriptor_name":"Trastuzumab","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000068878","descriptor_name":"Trastuzumab","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000178","descriptor_name":"Acrylamides","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000178","descriptor_name":"Acrylamides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000634","descriptor_name":"Aminoquinolines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000634","descriptor_name":"Aminoquinolines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018719","descriptor_name":"Erb-b2 Receptor Tyrosine Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D020360","descriptor_name":"Neoadjuvant Therapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.ctrv.2025.102901","doi":"https://doi.org/10.1016/j.ctrv.2025.102901","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ctrv.2025.102901","pdf_url":"https://www.cancertreatmentreviews.com/article/S0305-7372(25)00023-4/pdf","source":{"id":"https://openalex.org/S49831067","display_name":"Cancer Treatment Reviews","issn_l":"0305-7372","issn":["0305-7372","1532-1967"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Treatment Reviews","raw_type":"journal-article"},{"id":"pmid:39986012","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/39986012","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer treatment reviews","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1016/j.ctrv.2025.102901","doi":"https://doi.org/10.1016/j.ctrv.2025.102901","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ctrv.2025.102901","pdf_url":"https://www.cancertreatmentreviews.com/article/S0305-7372(25)00023-4/pdf","source":{"id":"https://openalex.org/S49831067","display_name":"Cancer Treatment Reviews","issn_l":"0305-7372","issn":["0305-7372","1532-1967"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Treatment Reviews","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/systematic-review","display_name":"Systematic Review"},{"id":"https://openalex.org/study-designs/meta-analysis","display_name":"Meta-Analysis"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4407636645.pdf","grobid_xml":"https://content.openalex.org/works/W4407636645.grobid-xml"},"referenced_works_count":31,"referenced_works":["https://openalex.org/W2121415567","https://openalex.org/W2134833483","https://openalex.org/W2379981061","https://openalex.org/W2774227900","https://openalex.org/W2796088951","https://openalex.org/W2802528458","https://openalex.org/W2922684335","https://openalex.org/W2995808512","https://openalex.org/W3006134372","https://openalex.org/W3082942945","https://openalex.org/W3127064904","https://openalex.org/W3128646645","https://openalex.org/W4205724345","https://openalex.org/W4210277918","https://openalex.org/W4211005384","https://openalex.org/W4283030645","https://openalex.org/W4288610056","https://openalex.org/W4296251815","https://openalex.org/W4311672849","https://openalex.org/W4313248733","https://openalex.org/W4313546418","https://openalex.org/W4318586343","https://openalex.org/W4380291236","https://openalex.org/W4387310591","https://openalex.org/W4388719682","https://openalex.org/W4389946263","https://openalex.org/W4390589881","https://openalex.org/W4396941016","https://openalex.org/W4401032153","https://openalex.org/W6760235838","https://openalex.org/W6858132192"],"related_works":["https://openalex.org/W4399323925","https://openalex.org/W4200123554","https://openalex.org/W4322773917","https://openalex.org/W4399141925","https://openalex.org/W4387825971","https://openalex.org/W4393162125","https://openalex.org/W4410814678","https://openalex.org/W3090147133","https://openalex.org/W4220739638","https://openalex.org/W4392377673"],"abstract_inverted_index":{"INTRODUCTION:":[0],"HER2-positive":[1,32,101,139,379],"breast":[2,33,65,102,140,147,193,380],"cancer":[3,141],"is":[4,37,69,419],"an":[5,373],"aggressive":[6],"subtype":[7],"that":[8,17,343,354],"benefits":[9],"from":[10],"targeted":[11],"therapies.":[12],"Some":[13],"studies":[14,125,134,137,218],"have":[15],"shown":[16],"pyrotinib":[18,50,83,168,390],"(P)":[19],"plus":[20,51,169,174,391,404],"trastuzumab":[21,52,86,88,94,171,175,267,370,387,392,405,412],"(H)":[22],"has":[23],"a":[24,107,261,302,383],"good":[25],"efficacy":[26,46,79,385,397],"against":[27],"early":[28,61],"or":[29,62,159,172],"locally":[30,63],"advanced":[31,64],"cancer.":[34,66,103],"However,":[35,389],"there":[36],"still":[38],"no":[39,240],"systematic":[40,72,108],"review":[41,73],"and":[42,47,74,80,93,120,135,189,200,225,342],"meta-analysis":[43,75,284],"supporting":[44],"the":[45,57,70,78,97,114,183,211,326,424],"safety":[48,81],"of":[49,60,82,100,154,206,216,285,305,321,426],"versus":[53,87],"standard":[54],"regimens":[55],"in":[56,96,111,243,264,283],"neoadjuvant":[58,98,177,375],"treatment":[59,99,376],"This":[67,278],"study":[68,224],"first":[71],"to":[76,128,246,325],"compare":[77],"combined":[84,89,166,368],"with":[85,90,138,164,167,369,382,399,408,423],"pertuzumab":[91,173],"(Per)":[92],"monotherapy":[95,268],"METHODS:":[104],"We":[105],"conducted":[106],"literature":[109],"search":[110],"PubMed,":[112],"Embase,":[113],"Cochrane":[115],"Library,":[116],"CNKI,":[117],"Wan":[118],"Fang":[119],"VIP":[121],"databases":[122],"for":[123,332,344,355,378],"relevant":[124],"published":[126],"up":[127],"August":[129],"30th,":[130],"2024.":[131],"RCTs,":[132,220],"cohort":[133,223],"retrospective":[136,227],"patients":[142,231],"who":[143],"had":[144,301],"not":[145,394],"received":[146],"cancer-related":[148],"treatments":[149],"previously":[150],"were":[151,232],"included.":[152,233],"Treatment":[153],"P":[155,235,297,416],"+":[156,161,236,248,298,335,347,358,362,401,417,428],"H,":[157,338],"H":[158,162,237,249,299,327,336,348,359,418],"Per":[160,247,361,400,427],"arms":[163],"chemotherapy":[165],"trastuzumab,":[170],"as":[176],"treatment.":[178],"The":[179,204,234,296,329],"primary":[180],"outcome":[181],"was":[182,208,280,340,351,364,406],"total":[184,215],"pathological":[185,194],"complete":[186,195],"response":[187,196],"(tpCR),":[188],"secondary":[190],"outcomes":[191],"included":[192],"(bpCR),":[197],"ORR,":[198],"DCR,":[199],"grade":[201,306],"III/IV":[202,307],"AEs.":[203],"quality":[205,331],"evidence":[207,330],"assessed":[209],"using":[210],"GRADE.":[212],"RESULTS:":[213],"A":[214],"nine":[217],"(4":[219],"1":[221],"prospective":[222],"4":[226],"analysis)":[228],"involving":[229],"1745":[230],"arm":[238,300],"showed":[239],"significant":[241,262],"difference":[242],"tpCR":[244,265,333,345,356],"compared":[245,324,398,422],"(RR:":[250,269,287,309],"0.94,":[251],"95":[252,271,289,311],"%":[253,272,290,312],"CI:":[254,273,291,313],"0.80-1.11,":[255],"p":[256,275,293,315],"=":[257],"0.46)":[258],"but":[259,318],"demonstrated":[260],"improvement":[263],"over":[266,386],"1.83,":[270],"1.56-2.15,":[274],"<":[276,294,316],"0.001).":[277,295],"finding":[279],"further":[281],"confirmed":[282],"RCTs":[286],"1.87,":[288],"1.42-2.47,":[292],"higher":[303],"incidence":[304],"diarrhea":[308],"10.54,":[310],"5.96-18.63,":[314],"0.001)":[317],"similar":[319],"rates":[320],"other":[322],"AEs":[323],"arm.":[328],"(P":[334,346,357],"vs.":[337,349,360],"RCT)":[339],"high,":[341],"H)":[350,363],"moderate,":[352],"while":[353],"low.":[365],"CONCLUSIONS:":[366],"Pyrotinib":[367,403],"may":[371],"offer":[372],"effective":[374],"option":[377],"cancer,":[381],"superior":[384],"alone.":[388],"did":[393],"show":[395],"better":[396],"H.":[402,429],"associated":[407],"more":[409],"diarrhrea":[410],"than":[411],"monotherapy.":[413],"In":[414],"addition,":[415],"less":[420],"cost-effective":[421],"combination":[425]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":4}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2025-02-18T00:00:00"}